Co-diagnostics Inc (CODX) — 13F Filings Explorer (Q2 2026)

CODX ranks #7984 out of 37696 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

CODX is a disclosed holding of Jane Street (Jane Street Group), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

24 institutions disclose a position in CODX, but none treat it as a major bet — even Armistice Capital, LLC, its most concentrated holder, allocates just 0.0% of its own portfolio to it.

CODX is down 8.5% today, but institutions show net buying of $1.7M this quarter — a divergence between today's price move and the underlying institutional flow.

CODX reported a net loss of $47.1M over the trailing twelve months.

• Not yet profitable — net loss of $47.1M over the trailing twelve months
• Revenue declined 28.1% year over year
• Net income declined year over year, from -$36.0M to -$47.1M
• Operating cash flow was negative, using $29.1M in cash
• Current ratio of 3.87x — enough short-term assets to cover short-term liabilities
• Liabilities run 60.77x equity — a highly leveraged balance sheet worth noting